Tag: carrier screening market top players

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Carrier Screening Industry Compare Between 2025 And 2029?

The carrier screening market has seen swift growth in recent years. It is anticipated to expand from $2.72 billion in 2024 to $3.16 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.2%. This past growth can be ascribed to several factors, including heightened awareness of genetic disorders, an increase in maternal age, greater understanding of family planning and pregnancy, efforts to prevent genetic diseases, various public health initiatives, and an intensified focus on inherited conditions.

The carrier screening market is anticipated to experience substantial expansion over the next few years. It is forecast to achieve a valuation of $5.72 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.0%. This projected growth stems from advancements in precision medicine, the availability of broader panel offerings, the proliferation of consumer genomics and direct-to-consumer testing, a heightened focus on rare and ultra-rare diseases, support from government and insurance bodies, and the integration of pharmacogenomics. Significant trends expected during this period involve progress in genetic technologies, integration with prenatal testing, the increasing prevalence of personalized medicine, the provision of counseling and education services, and careful consideration of ethical and legal aspects.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

Which Major Market Drivers Are Shaping The Future Of The Carrier Screening Market?

The carrier screening market is projected to grow due to an escalation in fetal chromosomal abnormalities and genetic disorders. Fetal chromosomal abnormalities describe a fetus having an irregular number of chromosomes or an unusual quantity of DNA within a chromosome. The objective of prenatal testing for chromosomal abnormalities is to accurately assess a patient’s risk of carrying a fetus with such a disorder. For instance, in February 2022, estimates from the World Health Organization, a global health agency based in Switzerland, indicated that birth defects result in the deaths of 240 000 newborns annually within their first 28 days of life. An additional 170,000 children between the ages of 1 month and 5 years die due to birth defects. Furthermore, an article published by the Government of United Nations in March 2022 stated that Down syndrome is estimated to affect 1 in 1,000 to 1 in 1,100 live births worldwide. Each year, between 3,000 and 5,000 children are born with this particular chromosome disorder. Therefore, the rising incidence of fetal chromosomal abnormalities and genetic disorders is a key driver for the growth of the carrier screening market.

How Is The Carrier Screening Market Classified Into Different Segments?

The carrier screeningmarket covered in this report is segmented –

1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions; Other Medical Conditions

3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies

4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics; Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES); Next-Generation Sequencing (NGS) Panels; Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests; Disease-Specific Panels; Ethnic Or Population-Specific Screening Tests

Which Trends Are Impacting The Carrier Screening Market?

Leading companies in the carrier screening market are concentrating on developing new products, such as screening test families, to secure their position. Screening tests are medical procedures or assessments conducted on individuals who show no symptoms of a particular disease or condition. For instance, in June 2023, Blueprint Genetics, a Finland-based company specializing in genetic testing and diagnostics, launched a new product named the Screening Tests family. This offering is tailored for specific applications like pregnancy, family planning, and comprehensive health evaluations for asymptomatic individuals. The purpose is to identify any increased risks, thereby enabling individuals to make well-informed decisions concerning family planning and health. Blueprint Genetics seeks to deliver actionable insights that allow for proactive choices based on the options available, highlighting its dedication to helping individuals make informed decisions about their future well-being.

Who Are The Prominent Global Companies Shaping The Carrier Screening Market?

Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

What Are The Regional Market Dynamics Impacting The Carrier Screening Industry?

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Carrier Screening Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

Browse Through More Reports Similar to the Global Carrier Screening Market 2025, By The Business Research Company

Medical Radiation Detection Monitoring And Safety Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-radiation-detection-monitoring-and-safety-global-market-report

Preventive Healthcare Technologies And Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/preventive-healthcare-technologies-and-services-global-market-report

Live Cell Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/live-cell-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Carrier Screening Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

In recent years, the carrier screening market has experienced a notable expansion. The market, which was valued at $2.72 billion in 2024, is projected to escalate to $3.16 billion in 2025, showing a compound annual growth rate (CAGR) of 16.2%. Factors such as rising awareness of genetic disorders, an increase in maternal age, heightened understanding about family planning and pregnancy, efforts to prevent genetic diseases, public health campaigns, and a heightened emphasis on inherited conditions can be seen as reasons for the growth in the historical period._x000D_

_x000D_

In the coming years, it is anticipated that the carrier screening market will undergo swift expansion, reaching a value of$5.72 billion in 2029″ with a 16.0% compound annual growth rate (CAGR). This growth during the projected period is a result of advancements in precision medicine, a broadened range of panel offerings, an emphasis on consumer genomics and direct-to-consumer testing, a focus on rare and ultra-rare diseases, and support from government and insurance bodies. The integration of pharmacogenomics is also a key factor. Leading trends during this period include the continued evolution of genetic technology, the fusion with prenatal testing, an increase in personalized medicine, the provision of counseling and educational services, and issues related to ethics and legality._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Carrier Screening Market?#_x000D_

The carrier screening market is anticipated to grow due to the rise in fetal chromosomal abnormalities and genetic disorders. Fetal chromosomal abnormalities are characterized by an unusual number of chromosomes in a fetus, along with an abnormal DNA amount within a chromosome. The purpose of prenatal testing for these abnormalities is to provide an accurate risk evaluation of a patient carrying a fetus with a chromosomal disorder. For example, as per the World Health Organization’s estimates in February 2022, about 240,000 newborns succumb in their first 28 days of life annually due to birth defects. Additionally, birth defects claim the lives of about 170,000 children aged between 1 month and 5 years. Furthermore, an article released by the Government of United Nations in March 2022, estimates that Down syndrome affects 1 in 1,000 to 1 in 1,100 live births globally. Each year, around 3,000 to 5,000 children are born with this chromosomal disorder. Therefore, the escalating instances of fetal chromosomal abnormalities and genetic disorders are fueling the expansion of the carrier screening market._x000D_

_x000D_

#Which Key Market Segments Comprise the Carrier Screening Market and Drive Its Revenue Growth?#_x000D_

The carrier screeningmarket covered in this report is segmented – _x000D_

_x000D_

1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening _x000D_

2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions; Other Medical Conditions _x000D_

3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies _x000D_

4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics; Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES); Next-Generation Sequencing (NGS) Panels; Comprehensive Carrier Screening Tests_x000D_

2) By Targeted Disease Carrier Screening: Single Gene Tests; Disease-Specific Panels; Ethnic Or Population-Specific Screening Tests_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Carrier Screening Market Expansion Across the Globe?#_x000D_

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Key Market Trends in theCarrier Screening Market Over the Coming Years?#_x000D_

Key companies in the carrier screening market are directing their efforts towards the development of new products, such as family screening tests, in order to maintain market dominance. These screening tests are healthcare procedures or tests given to people who show no signs of any specific disease or condition. For example, Blueprint Genetics, a company based in Finland that focuses on genetic testing and diagnostics, rolled out a new service in June 2023 named the Screening Tests family. Tailored for specific uses like pregnancy, family planning, and general health screenings for those without symptoms, its aim is to detect increased risks, thus enabling individuals to make knowledge-based decisions about their family planning and health. Blueprint Genetics is committed to providing actionable data that allows individuals to make proactive decisions based on a range of options, demonstrating a dedication to assisting individuals in making educated choices for their future health and well-being._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report_x000D_

_x000D_

#How Is the Carrier Screening Market Conceptually Defined?#_x000D_

Carrier screening refers to a type of genetic test that can determine if there is a gene that causes certain genetic illnesses. The carrier screening is used to identify people who have one copy of a gene mutation that produces a hereditary illness when two copies are present._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Carrier Screening Market Growth Performance Trended Historically, And What Lies Ahead?

In recent years, the carrier screening market has experienced a notable expansion. The market, which was valued at $2.72 billion in 2024, is projected to escalate to $3.16 billion in 2025, showing a compound annual growth rate (CAGR) of 16.2%. Factors such as rising awareness of genetic disorders, an increase in maternal age, heightened understanding about family planning and pregnancy, efforts to prevent genetic diseases, public health campaigns, and a heightened emphasis on inherited conditions can be seen as reasons for the growth in the historical period.

In the coming years, it is anticipated that the carrier screening market will undergo swift expansion, reaching a value of$5.72 billion in 2029″ with a 16.0% compound annual growth rate (CAGR). This growth during the projected period is a result of advancements in precision medicine, a broadened range of panel offerings, an emphasis on consumer genomics and direct-to-consumer testing, a focus on rare and ultra-rare diseases, and support from government and insurance bodies. The integration of pharmacogenomics is also a key factor. Leading trends during this period include the continued evolution of genetic technology, the fusion with prenatal testing, an increase in personalized medicine, the provision of counseling and educational services, and issues related to ethics and legality.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Carrier Screening Market?

The carrier screening market is anticipated to grow due to the rise in fetal chromosomal abnormalities and genetic disorders. Fetal chromosomal abnormalities are characterized by an unusual number of chromosomes in a fetus, along with an abnormal DNA amount within a chromosome. The purpose of prenatal testing for these abnormalities is to provide an accurate risk evaluation of a patient carrying a fetus with a chromosomal disorder. For example, as per the World Health Organization’s estimates in February 2022, about 240,000 newborns succumb in their first 28 days of life annually due to birth defects. Additionally, birth defects claim the lives of about 170,000 children aged between 1 month and 5 years. Furthermore, an article released by the Government of United Nations in March 2022, estimates that Down syndrome affects 1 in 1,000 to 1 in 1,100 live births globally. Each year, around 3,000 to 5,000 children are born with this chromosomal disorder. Therefore, the escalating instances of fetal chromosomal abnormalities and genetic disorders are fueling the expansion of the carrier screening market.

Which Key Market Segments Comprise the Carrier Screening Market and Drive Its Revenue Growth?

The carrier screeningmarket covered in this report is segmented –

1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions; Other Medical Conditions

3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies

4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics; Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES); Next-Generation Sequencing (NGS) Panels; Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests; Disease-Specific Panels; Ethnic Or Population-Specific Screening Tests

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

Which Areas Are Leading Regions in the Carrier Screening Market Expansion Across the Globe?

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theCarrier Screening Market Over the Coming Years?

Key companies in the carrier screening market are directing their efforts towards the development of new products, such as family screening tests, in order to maintain market dominance. These screening tests are healthcare procedures or tests given to people who show no signs of any specific disease or condition. For example, Blueprint Genetics, a company based in Finland that focuses on genetic testing and diagnostics, rolled out a new service in June 2023 named the Screening Tests family. Tailored for specific uses like pregnancy, family planning, and general health screenings for those without symptoms, its aim is to detect increased risks, thus enabling individuals to make knowledge-based decisions about their family planning and health. Blueprint Genetics is committed to providing actionable data that allows individuals to make proactive decisions based on a range of options, demonstrating a dedication to assisting individuals in making educated choices for their future health and well-being.

View the full report here:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

How Is the Carrier Screening Market Conceptually Defined?

Carrier screening refers to a type of genetic test that can determine if there is a gene that causes certain genetic illnesses. The carrier screening is used to identify people who have one copy of a gene mutation that produces a hereditary illness when two copies are present.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Carrier Screening Market Grown from 2024 to 2025?

In recent times, the carrier screening market has witnessed a fast-paced expansion. The market, which stood at $2.72 billion in 2024, is predicted to escalate to $3.17 billion in 2025, marking a compound annual growth rate (CAGR) of 16.4%. Factors like heightened awareness about genetic disorders, an increase in maternal age, focused family planning and pregnancy consciousness, prevention attempts for genetic diseases, public health measures, and a heightened interest in hereditary conditions, contributed to the growth in the historic term.

What Growth Rate Is Anticipated for the Carrier Screening Market in the Coming Years?

In the coming years, the carrier screening market is projected to experience a swift expansion. By 2029, it is anticipated to reach a value of $5.76 billion with a Compound Annual Growth Rate (CAGR) of 16.2%. Factors contributing to the anticipated growth in the forecast period include advancements in precision medicine, expanded panel offerings, consumer genomics and direct-to-consumer testing, focus on uncommon and extremely rare diseases, support from government and insurance, and the integration of pharmacogenomics. Key trends expected during the forecast period include advancements in genetic technologies, integration of prenatal testing, rise in personalized medicine, utilization of counseling and education services, as well as, ethical and legal considerations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

Who Are the Leading Companies in the Carrier Screening Market?

Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

What Are the Key Drivers of the Carrier Screening Market?

The upsurge in fetal chromosomal anomalies and genetic ailments will undoubtedly stimulate the expansion of the carrier screening market. Fetal chromosomal anomalies involve an aberrant sum of chromosomes inside a fetus, along with an irregular magnitude of DNA within a chromosome. The objective of testing pregnant women for chromosomal abnormalities is to provide a precise estimation of the risk of carrying a fetus with a chromosomal disease. For instance, the World Health Organization, a global health body based in Switzerland, estimated in February 2022 that birth defects are responsible for the loss of approximately 240,000 newborns within their first 28 days of life annually. An added 170,000 kids varying from a month to five years of age die as a repercussion of birth defects. Moreover, according to a report provided by the Government of United Nations in March 2022, Down syndrome is guessed to impact 1 in 1,000 to 1 in 1,100 live births globally. This chromosomal ailment births between 3,000 and 5,000 children every year. Consequently, the rise in fetal chromosomal abnormalities and genetic disorders is steering the advancement of the carrier screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

What Are the Key Market Segments in the Carrier Screening Industry?

The carrier screening market covered in this report is segmented –

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions

3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

4) By End User: Hospitals, Reference Laboratories, Physician Offices And Clinics, Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS) Panels, Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests, Disease-Specific Panels, Ethnic Or Population-Specific Screening Tests

What Are the Latest Trends in the Carrier Screening Market?

Key players in the carrier screening market are concentrating on creating new products like screening test families to maintain their market standing. Screening tests are medical examinations or tests done on people who are not experiencing any symptoms of a specific disease or condition. For example, Blueprint Genetics, a Finnish organization specializing in genetic testing and diagnostics, launched a new product called the Screening Tests family in June 2023. The product is developed for particular purposes like pregnancy, family planning, and comprehensive health checks for asymptomatic individuals. The aim is to highlight any increased risks, enabling people to make knowledgeable decisions about family planning and health. Blueprint Genetics’ goal is to provide actionable data that facilitates proactive choices based on the options available, underscoring a dedication to aiding people in making educated decisions about their future health.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

What Are the Key Regional Markets in the Carrier Screening Industry?

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

This Report Delivers Insight On:

1. How big is the carrier screening market, and how is it changing globally?

2. Who are the major companies in the carrier screening market, and how are they performing?

3. What are the key opportunities and risks in the carrier screening market right now?

4. Which products or customer segments are growing the most in the carrier screening market?

5. What factors are helping or slowing down the growth of the carrier screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Carrier Screening Market Grown from 2024 to 2025?

In recent times, the carrier screening market has witnessed a fast-paced expansion. The market, which stood at $2.72 billion in 2024, is predicted to escalate to $3.17 billion in 2025, marking a compound annual growth rate (CAGR) of 16.4%. Factors like heightened awareness about genetic disorders, an increase in maternal age, focused family planning and pregnancy consciousness, prevention attempts for genetic diseases, public health measures, and a heightened interest in hereditary conditions, contributed to the growth in the historic term.

What Growth Rate Is Anticipated for the Carrier Screening Market in the Coming Years?

In the coming years, the carrier screening market is projected to experience a swift expansion. By 2029, it is anticipated to reach a value of $5.76 billion with a Compound Annual Growth Rate (CAGR) of 16.2%. Factors contributing to the anticipated growth in the forecast period include advancements in precision medicine, expanded panel offerings, consumer genomics and direct-to-consumer testing, focus on uncommon and extremely rare diseases, support from government and insurance, and the integration of pharmacogenomics. Key trends expected during the forecast period include advancements in genetic technologies, integration of prenatal testing, rise in personalized medicine, utilization of counseling and education services, as well as, ethical and legal considerations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

Who Are the Leading Companies in the Carrier Screening Market?

Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

What Are the Key Drivers of the Carrier Screening Market?

The upsurge in fetal chromosomal anomalies and genetic ailments will undoubtedly stimulate the expansion of the carrier screening market. Fetal chromosomal anomalies involve an aberrant sum of chromosomes inside a fetus, along with an irregular magnitude of DNA within a chromosome. The objective of testing pregnant women for chromosomal abnormalities is to provide a precise estimation of the risk of carrying a fetus with a chromosomal disease. For instance, the World Health Organization, a global health body based in Switzerland, estimated in February 2022 that birth defects are responsible for the loss of approximately 240,000 newborns within their first 28 days of life annually. An added 170,000 kids varying from a month to five years of age die as a repercussion of birth defects. Moreover, according to a report provided by the Government of United Nations in March 2022, Down syndrome is guessed to impact 1 in 1,000 to 1 in 1,100 live births globally. This chromosomal ailment births between 3,000 and 5,000 children every year. Consequently, the rise in fetal chromosomal abnormalities and genetic disorders is steering the advancement of the carrier screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

What Are the Key Market Segments in the Carrier Screening Industry?

The carrier screening market covered in this report is segmented –

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions

3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

4) By End User: Hospitals, Reference Laboratories, Physician Offices And Clinics, Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS) Panels, Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests, Disease-Specific Panels, Ethnic Or Population-Specific Screening Tests

What Are the Latest Trends in the Carrier Screening Market?

Key players in the carrier screening market are concentrating on creating new products like screening test families to maintain their market standing. Screening tests are medical examinations or tests done on people who are not experiencing any symptoms of a specific disease or condition. For example, Blueprint Genetics, a Finnish organization specializing in genetic testing and diagnostics, launched a new product called the Screening Tests family in June 2023. The product is developed for particular purposes like pregnancy, family planning, and comprehensive health checks for asymptomatic individuals. The aim is to highlight any increased risks, enabling people to make knowledgeable decisions about family planning and health. Blueprint Genetics’ goal is to provide actionable data that facilitates proactive choices based on the options available, underscoring a dedication to aiding people in making educated decisions about their future health.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

What Are the Key Regional Markets in the Carrier Screening Industry?

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

This Report Delivers Insight On:

1. How big is the carrier screening market, and how is it changing globally?

2. Who are the major companies in the carrier screening market, and how are they performing?

3. What are the key opportunities and risks in the carrier screening market right now?

4. Which products or customer segments are growing the most in the carrier screening market?

5. What factors are helping or slowing down the growth of the carrier screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the carrier screening industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Carrier Screening Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, there has been a swift expansion in the size of the carrier screening market. The industry, which is projected to expand from $2.72 billion in 2024 to $3.17 billion in 2025, will demonstrate a compound annual growth rate (CAGR) of 16.4%. Factors such as heightened awareness of genetic disorders, an increase in maternal age, understanding of family planning and pregnancy, efforts to prevent genetic diseases, public health drive, and increased attention on inherited conditions are responsible for the growth experienced in the historical period.

In the forthcoming years, the carrier screening market is predicted to experience robust expansion and might reach a valuation of $5.76 billion by 2029, boasting a compound annual growth rate (CAGR) of 16.2%. The anticipated growth can be linked to developments in precision medicine, an increase in panel offerings, popularity of consumer genomics and individual testing, a focus on unusual and exceptionally rare diseases, and support from the government and insurance sectors. The integration of pharmacogenomics is also a considerable contributing factor. During the forecast period, advancements in genetic technologies, incorporation with prenatal testing, rise of personalized medicine, and services like counseling and education are the major trends. Ethical and legal predicaments will also play crucial roles.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

What Are the Core Growth Drivers Propelling the Carrier Screening Market Forward?

The rise in fetal chromosomal irregularities and genetic conditions is predicted to spur the expansion of the carrier screening market in the future. Fetal chromosomal irregularities denote a fetus bearing an unusual number of chromosomes, or unusual DNA amounts within a chromosome. Chromosomal abnormality prenatal tests are designed to give a precise evaluation of a patient’s likelihood of bearing a fetus with a chromosomal condition. For instance, as per the World Health Organization’s estimate in February 2022, about 240,000 newborns lose their lives in the initial 28 days every year due to birth defects. Further, birth defects result in the death of another 170,000 children aged between 1 month and 5 years. Further, as per a report published by the United Nations Government in March 2022, it is estimated that Down syndrome affects 1 in every 1,000 to 1 in 1,100 live births globally. The annual count of children born with this chromosomal disorder ranges between 3,000 and 5,000. Therefore, the increment of fetal chromosomal anomalies and genetic disorders is the impetus behind the growth of the carrier screening market.

What Segment Types Define the Carrier Screening Market Structure?

The carrier screening market covered in this report is segmented –

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions

3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

4) By End User: Hospitals, Reference Laboratories, Physician Offices And Clinics, Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS) Panels, Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests, Disease-Specific Panels, Ethnic Or Population-Specific Screening Tests

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Carrier Screening Market?

North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theCarrier Screening Industry Evolution?

Dominant businesses in the carrier screening market are concentrating on innovation in product development, such as family screening tests, to maintain their market position. Carrier screening tests are medical procedures conducted on individuals who show no signs of a specific disease or condition. For example, in June 2023, Blueprint Genetics, a Finnish company that specializes in genetic testing and diagnostics, launched a new product named the Screening Tests family. This product is tailored for specific uses like pregnancy, family planning, and exhaustive health evaluations for people without any symptoms. The goal is to recognize any elevated risks, enabling people to make knowledgeable decisions about family planning and their health. Blueprint Genetics is committed to providing actionable information to support proactive decision-making based on familiar options, highlighting their dedication to assisting individuals make informed choices about their future health.

View the full report here:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

What Is the Definition of the Carrier Screening Market?

Carrier screening refers to a type of genetic test that can determine if there is a gene that causes certain genetic illnesses. The carrier screening is used to identify people who have one copy of a gene mutation that produces a hereditary illness when two copies are present.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theCarrier Screening Market from 2025 to 2034?

The anticipated rise in occurrences of fetal chromosomal abnormalities and genetic diseases is set to boost expansion in the carrier screening market. Fetal chromosomal abnormalities essentially entail fetuses bearing an unusual number of chromosomes or having an abnormal amount of DNA within a chromosome. Chromosomal irregularities are usually assessed through prenatal testing to accurately determine the likelihood of a patient carrying a fetus with these disorders. For instance, the World Health Organization, a global health organization based in Switzerland, reported in February 2022 that congenital defects account for 240,000 neonatal deaths in the first 28 days of life annually. An additional 170,000 offspring aged between 1 month and 5 years also succumb due to birth defects. Furthermore, in March 2022, an article released by the United Nations Government concluded that Down syndrome affects between 1 in 1,000 and 1 in 1,100 live births globally. Each year, the disorder contributes to the birth of 3,000 to 5,000 children. Consequently, the increasing incidences of fetal chromosomal irregularities and genetic disorders are accelerating the expansion of the carrier screening market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

#What is the Growth Potential of the Carrier Screening Market, and How Will It Perform by 2034?

In recent years, there has been a considerable expansion in the carrier screening market. It is projected to increase from a value of $2.72 billion in 2024 to $3.17 billion in 2025, displaying a compound annual growth rate (CAGR) of 16.4%. This growth during the historical period is ascribed to factors such as heightened awareness towards genetic disorders, increase in maternal age, awareness of family planning and pregnancy, efforts towards genetic disease prevention, public health initiatives, and a concentrated focus on inherited conditions.

It is projected that the carrier screening industry will experience substantial expansion in the coming years, potentially reaching a valuation of $5.76 billion in 2029 with a CAGR of 16.2%. This growth during the estimated period is credited to advancements in precision medicine, the provision of expanded panels, the rise of consumer genomics and direct-to-consumer testing, a focus on rare and ultra-rare diseases, government and insurance support, as well as the incorporation of pharmacogenomics. Noteworthy trends forecasted for this period encompass advancements in genetic technologies, the amalgamation with prenatal testing, the surge of personalized medicine, the availability of counselling and educational services and the consideration of ethical and legal factors.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

How Are Market Trends and Innovations Revolutionizing the Carrier Screening Industry in Recent Times?

Key businesses in the carrier screening market are focusing on product innovation, such as the creation of screening tests, to maintain their competitive standing. These screening procedures are conducted on individuals who show no signs of a given illness or condition. For instance, in June 2023, Blueprint Genetics, a genetics testing and diagnostics company from Finland, launched a novel product named the Screening Tests family. This product is devised for specific uses like pregnancy, family planning and exhaustive health assessments for individuals not showing any symptoms. The aim is to detect any elevated risks, enabling individuals to make educated decisions about family planning and health. Blueprint Genetics intends to provide valuable data that encourages proactive choices based on the options available, underscoring a commitment to assist individuals in making knowledgeable choices regarding their future health.

Which Key Market Players Are Shaping the Future and Growth of theCarrier Screening Market?

Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

What Are the Core Segments of the Carrier Screening Market, and How Do They Contribute to Growth?

The carrier screening market covered in this report is segmented –

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening

2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions

3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

4) By End User: Hospitals, Reference Laboratories, Physician Offices And Clinics, Other End Users

Subsegments:

1) By Expanded Carrier Screening: Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS) Panels, Comprehensive Carrier Screening Tests

2) By Targeted Disease Carrier Screening: Single Gene Tests, Disease-Specific Panels, Ethnic Or Population-Specific Screening Tests

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7952&type=smpGlobal Carrier Screening Market, Global Carrier Screening Market Report, Global Carrier Screening Market Trends, Global Carrier Screening Market Size

Browse Through More Reports Similar to the Gobal Carrier Screening Maret 2025, By The Business Research Company:

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Medical Radiation Detection, Monitoring & Safety Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-radiation-detection-monitoring-and-safety-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: